Results 111 to 120 of about 1,965,502 (401)

ST-Segment Elevation in Patients with Covid-19 — A Case Series

open access: yesNew England Journal of Medicine, 2020
ST-Segment Elevation in Covid-19 Eighteen patients with Covid-19 presented with ST-segment elevation on ECG or had it develop during hospitalization.
S. Bangalore   +14 more
semanticscholar   +1 more source

Cardiac manifestations of PRKAG2 mutation. [PDF]

open access: yes, 2018
BACKGROUND:The Protein Kinase AMP-Activated Non-Catalytic Subunit Gamma 2 (PRKAG2) cardiac syndrome is characterized by glycogen accumulation in the cardiac tissue.
Ardehali, Reza   +3 more
core   +1 more source

PARP inhibitors elicit distinct transcriptional programs in homologous recombination competent castration‐resistant prostate cancer

open access: yesMolecular Oncology, EarlyView.
PARP inhibitors are used to treat a small subset of prostate cancer patients. These studies reveal that PARP1 activity and expression are different between European American and African American prostate cancer tissue samples. Additionally, different PARP inhibitors cause unique and overlapping transcriptional changes, notably, p53 pathway upregulation.
Moriah L. Cunningham   +21 more
wiley   +1 more source

Transient elevation of ST-segment due to pneumothorax and pneumopericardium

open access: yesAutopsy and Case Reports, 2013
ST-segment elevation, observed in the critically ill patients, almost always raises the suspicion of ischemic heart disease. However, nonischemic myocardial and non-myocardial problems in these patients may also lead to ST-segment elevation. Pneumothorax
Rodrigo Martins Brandão   +5 more
doaj   +1 more source

Adenosine‐to‐inosine editing of miR‐200b‐3p is associated with the progression of high‐grade serous ovarian cancer

open access: yesMolecular Oncology, EarlyView.
A‐to‐I editing of miRNAs, particularly miR‐200b‐3p, contributes to HGSOC progression by enhancing cancer cell proliferation, migration and 3D growth. The edited form is linked to poorer patient survival and the identification of novel molecular targets.
Magdalena Niemira   +14 more
wiley   +1 more source

Perbedaan Antara Terapi Fibrinolitik Dan Heparinisasi Terhadap Perubahan St-Elevasi Pada Penderita Infark Miokard Akut Di RSUD Moewardi [PDF]

open access: yes, 2015
Background. Acute myocardial infarction with ST-elevation (STEMI) was a necrotic area resulted from total occlusion on the blood vessel wall, which lead to accumulation of extracellular K +. Fibrinolytic therapy had a big role solving the thrombus formed,
, dr. Listiana Masyita Dewi, M.Sc   +2 more
core  

Squamous Cell Carcinoma Metastatic to the Heart Mimicking ST-Elevation Myocardial Infarction [PDF]

open access: yes, 2016
INTRODUCTION Heart disease remains the leading cause of mortality in the United States, accounting for about one quarter of all deaths in 20131.
Chen, MD, Jason   +3 more
core   +2 more sources

In vitro properties of patient serum predict clinical outcome after high dose rate brachytherapy of hepatocellular carcinoma

open access: yesMolecular Oncology, EarlyView.
Following high dose rate brachytherapy (HDR‐BT) for hepatocellular carcinoma (HCC), patients were classified as responders and nonresponders. Post‐therapy serum induced increased BrdU incorporation and Cyclin E expression of Huh7 and HepG2 cells in nonresponders, but decreased levels in responders.
Lukas Salvermoser   +14 more
wiley   +1 more source

Tombstoning ST-Elevation Myocardial Infarction [PDF]

open access: yesCurrent Cardiology Reviews, 2009
Tombstoning ST elevation myocardial infarction can be described as a STEMI characterized by tombstoning ST-segment elevation. This myocardial infarction is associated with extensive myocardial damage, reduced left ventricle function, serious hospital complications and poor prognosis.
openaire   +2 more sources

Home - About - Disclaimer - Privacy